The Evolution of Diagnosis and Management of Pediatric Biliary Tract Rhabdomyosarcoma

Alpin D Malkan, Israel Fernandez-Pineda1

  • 1Department of Surgery St. Jude Children's Research Hospital 262 Danny Thomas Place Memphis, TN-USA. israel.fernandez-pineda@stjude.org.

Current Pediatric Reviews
|January 19, 2016
PubMed

Insights

Pediatric biliary tract rhabdomyosarcoma (RMS) management has evolved from radical surgery to multimodal approaches. This rare childhood cancer diagnosis and treatment remain challenging, prioritizing cure and quality of life.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Pediatric Radiology

Background:

  • Pediatric biliary tract masses present diagnostic challenges.
  • Rhabdomyosarcoma (RMS) is a rare pediatric malignancy affecting the biliary tract.

Purpose of the Study:

  • To provide an overview of the evolving management strategies for pediatric biliary tract rhabdomyosarcoma.
  • To highlight the diagnostic and therapeutic challenges associated with this rare entity.

Main Methods:

  • Review of clinical research on pediatric biliary tract RMS.
  • Focus on diagnosis, staging, and treatment evolution.

Main Results:

  • Management shifted from radical surgery with poor outcomes to multimodal therapy (chemotherapy and tailored surgery).
  • Diagnosis remains challenging due to rarity and potential confusion with other conditions like choledochal cysts.
  • Multimodal approaches have improved outcomes for childhood RMS.

Conclusions:

  • Biliary tract RMS is rare but the most common neoplastic cause of biliary obstruction in children.
  • Current management aims to balance cure, quality of life, and minimizing morbidity/mortality.
  • Effective management requires a case-specific, multimodal approach.
Abstract

Related Concept Videos